Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events

International Journal of Impotence Research
E Bischoff

Abstract

Vardenafil potently inhibits human phosphodiesterase 5 (PDE5) with an IC50 of 0.7 nM. Enhancement of nitric oxide (NO)-induced erections in rabbits by 0.1 mg/kg vardenafil is limited by its pharmacokinetic properties (Tmax=1 h; T1/2=1.2 h), although erectile effects have been observed after 7 h. In humans, vardenafil is rapidly absorbed (Tmax approximately 40 min) and more slowly metabolized (T1/2 approximately 4 h), with an absolute bioavailability of 14.5% (vs 40% for sildenafil). Although the consumption of high-fat meals does not affect the drug's relative bioavailability, it retards intestinal absorption. Coadministration of CYP3A4 inhibitors such as ritonavir can affect hepatic metabolism. M1, an active metabolite of vardenafil, is a four-fold-less potent inhibitor of PDE5 than its parent compound, contributing approximately 7% to vardenafil's overall efficacy. The side effects of all selective PDE5 inhibitors commonly include vasodilation, small reductions in blood pressure, headache, and nasal congestion.

References

Apr 26, 2000·Behavioural Pharmacology·C M Baratti, M M Boccia
Apr 13, 2001·Journal of Cardiovascular Pharmacology·R BerkelsW Klaus
May 10, 2001·European Journal of Pharmacology·R Asomoza-EspinosaV Granados-Soto
Mar 14, 2002·International Journal of Impotence Research·I Saenz de TejadaE Bischoff
May 7, 2002·International Urology and Nephrology·M DündarH Erol
Jun 22, 2002·Archives of Internal Medicine·Howard A FinkTimothy J Wilt
Sep 10, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Christina KruuseJes Olesen
Nov 2, 2002·Stroke; a Journal of Cerebral Circulation·Ruilan ZhangMichael Chopp

❮ Previous
Next ❯

Citations

Nov 30, 2007·International Journal of Impotence Research·A R CamposV S N Rao
Mar 17, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Anindita DasRakesh C Kukreja
Oct 22, 2009·Pharmacogenomics·Ibrahim A Abdel-Hamid, Karl-Erik Andersson
Dec 18, 2013·Actas urologicas españolas·P R Gutiérrez-Hernández, P Rebollo
May 7, 2009·Expert Opinion on Drug Metabolism & Toxicology·Kevin R Rice, Robert C Dean
Jan 23, 2010·The Journal of Sexual Medicine·Ian EardleySung Won Lee
Jan 25, 2013·The Journal of Sexual Medicine·Hartmut PorstUNKNOWN ISSM Standards Committee for Sexual Medicine
May 10, 2006·The Journal of Sexual Medicine·Dimitrios MallisDimitrios Hatzichristou
Dec 10, 2015·Current Therapeutic Research, Clinical and Experimental·Majed M MasadehSayer I Al-Azzam
Sep 22, 2009·Journal of Internal Medicine·S Tajbakhsh
Mar 12, 2008·British Journal of Pharmacology·O MaasT Krieg
May 21, 2010·Rapid Communications in Mass Spectrometry : RCM·Sabina Strano-RossiFrancesco Botrè
Oct 17, 2009·IEEE Transactions on Visualization and Computer Graphics·Melanie ToryRebecca Dreezer
Jan 3, 2006·The American Journal of Cardiology·Culley C Carson
Jun 17, 2006·European Journal of Pharmacology·Lang-Chu Lau, P Ganesan Adaikan
May 17, 2013·Expert Opinion on Pharmacotherapy·Roberto BruzzichesAntonio Aversa
Oct 4, 2016·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·O A El-KawyR K Tuominen
Jan 27, 2007·The Cochrane Database of Systematic Reviews·M Vardi, A Nini
Oct 12, 2010·Clinical Drug Investigation·Roland HeinigMichael-Friedrich Böttcher
Aug 23, 2005·Phytotherapy Research : PTR·Binu Tharakan, Bala V Manyam
Nov 23, 2006·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M D LeeL Gong
Mar 1, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hei-Young KuKwang-Hyeon Liu
Nov 1, 2015·Biochemical Society Transactions·Beth CoyleIan D Kerr
Feb 23, 2021·Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents·Haizhou ZhuSwati S More

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.